Inventor · Berlin, DE

Gerd Wallukat

13Patents
3h-index
17Co-inventors
57Inventor score

Filing activity: Dec 22, 1999 → Mar 25, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US6994970B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM) Human Necessities 6 Expired
US7745139B1 Peptides of the AT1 receptor and their uses Human Necessities 4 Expired
US9272991B2 Eicosanoid derivatives Chemistry; Metallurgy 4 Active
US10287262B2 Eicosanoid derivatives Chemistry; Metallurgy 1 Active
US9234201B2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases Emerging Cross-Sectional Technologies 1 Active
US11365183B2 Eicosanoid derivatives Chemistry; Metallurgy 0 Active
US8455442B2 Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor Chemistry; Metallurgy 0 Active
US9862953B2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases Emerging Cross-Sectional Technologies 0 Active
US7741050B2 Identification of agonistic autoantibodies Emerging Cross-Sectional Technologies 0 Active
US9574017B2 Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor Chemistry; Metallurgy 0 Active
US8440609B2 Peptides against autoantibodies causing intolerance to cold and use thereof Chemistry; Metallurgy 0 Active
US11130772B2 CYP-eicosanoid derivatives Chemistry; Metallurgy 0 Active
US10266830B2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.